Markel Group Inc. acquired a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,000 shares of the financial services provider’s stock, valued at approximately $697,000.
Other large investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its stake in shares of CME Group by 1.8% during the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after purchasing an additional 142,692 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of CME Group during the fourth quarter valued at approximately $871,063,000. Janus Henderson Group PLC grew its stake in shares of CME Group by 17.8% during the third quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after purchasing an additional 380,071 shares during the last quarter. Capital Wealth Planning LLC grew its stake in shares of CME Group by 69.2% during the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock valued at $565,671,000 after purchasing an additional 996,498 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of CME Group by 70.4% during the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock valued at $544,157,000 after purchasing an additional 1,003,119 shares during the last quarter. 87.75% of the stock is owned by institutional investors.
Insiders Place Their Bets
In related news, insider Hilda Harris Piell sold 3,984 shares of the firm’s stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. This trade represents a 12.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the sale, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. The trade was a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,076 shares of company stock worth $4,271,496. Company insiders own 0.30% of the company’s stock.
CME Group Trading Up 3.0 %
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group announced that its Board of Directors has approved a share repurchase program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.
CME Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be issued a $1.25 dividend. The ex-dividend date is Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.91%. CME Group’s dividend payout ratio (DPR) is 51.71%.
Analyst Ratings Changes
CME has been the topic of several research analyst reports. Morgan Stanley increased their price target on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. Royal Bank of Canada increased their price target on shares of CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. Keefe, Bruyette & Woods increased their price target on shares of CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research note on Friday, February 14th. Piper Sandler raised their price objective on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Finally, JPMorgan Chase & Co. raised their price objective on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research note on Thursday, February 13th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, CME Group presently has a consensus rating of “Hold” and an average target price of $238.93.
View Our Latest Stock Analysis on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- What is Forex and How Does it Work?
- How to Protect Your Portfolio When Inflation Is Rising
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What Does Downgrade Mean in Investing?
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.